Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferdinando Varbella

Showing results (111-120 of 224) with videos related to

Pageof 23
Sort By:
The Journal of Invasive Cardiology|May 16, 2018
Unprotected Left Main Coronary Artery Disease: Outcomes of Treatment With Second-Generation Drug-Eluting Stents - Insight From the FAILS-2 StudyUmberto Barbero, Rahim Kanji, Enrico Cerrato, et al.
Giornale Italiano Di Cardiologia (2006)|March 26, 2015
[New Technologies in coronary interventional cardiology: results from the first inter-regional survey promoted by SICI-GISE in four regions of northern Italy ("the GISE TOLOVE" area: Tuscany, Lombardy, Veneto, Emilia-Romagna)]Marco Mojoli, Giuseppe Musumeci, Giuseppe Tarantini, et al.
American Heart Journal|December 15, 2012
A prospective, randomized trial of intravascular-ultrasound guided compared to angiography guided stent implantation in complex coronary lesions: the AVIO trialAlaide Chieffo, Azeem Latib, Christophe Caussin, et al.
The American Journal of Cardiology|January 30, 2017
Incidence and Management of Restenosis After Treatment of Unprotected Left Main Disease With Second-Generation Drug-Eluting Stents (from Failure in Left Main Study With 2nd Generation Stents-Cardiogroup III Study)Fabrizio D'Ascenzo, Alaide Chieffo, Enrico Cerrato, et al.
International Journal of Cardiology|October 11, 2017
Provisional versus elective two-stent strategy for unprotected true left main bifurcation lesions: Insights from a FAILS-2 sub-studyHiroyoshi Kawamoto, Alaide Chieffo, Fabrizio D'Ascenzo, et al.
European Heart Journal. Acute Cardiovascular Care|September 7, 2021
Acute kidney injury in patients with acute coronary syndrome undergoing invasive management treated with bivalirudin vs. unfractionated heparin: insights from the MATRIX trialAntonio Landi, Mattia Branca, Giuseppe Andò, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 16, 2017
One-year clinical results of the Italian diffuse/multivessel disease ABSORB prospective registry (IT-DISAPPEARS)Luca Testa, Marco De Carlo, Alessandro Petrolini, et al.
International Journal of Cardiology|April 25, 2018
Corrigendum to "Provisional versus elective two-stent strategy for unprotected true left main bifurcation lesions: Insights from a FAILS-2 sub-study" [Int. J. Cardiol. 250 (2018) 80-85]Hiroyoshi Kawamoto, Alaide Chieffo, Fabrizio D'Ascenzo, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|December 25, 2016
Comparison of paclitaxel drug-eluting balloon and paclitaxel-eluting stent in small coronary vessels in diabetic and nondiabetic patients - results from the BELLO (balloon elution and late loss optimization) trialFrancesco Giannini, Azeem Latib, Richard J Jabbour, et al.
The American Journal of Cardiology|January 2, 2021
Incidence, Management, Immediate and Long-Term Outcome of Guidewire and Device Related Grade III Coronary Perforations (from G3CAP - Cardiogroup VI Registry)Enrico Cerrato, Marco Pavani, Umberto Barbero, et al.
Pageof 23

Showing results (111-120 of 224) with videos related to

Sort By:
Pageof 23
The Journal of Invasive Cardiology|May 16, 2018
Unprotected Left Main Coronary Artery Disease: Outcomes of Treatment With Second-Generation Drug-Eluting Stents - Insight From the FAILS-2 StudyUmberto Barbero, Rahim Kanji, Enrico Cerrato, et al.
Giornale Italiano Di Cardiologia (2006)|March 26, 2015
[New Technologies in coronary interventional cardiology: results from the first inter-regional survey promoted by SICI-GISE in four regions of northern Italy ("the GISE TOLOVE" area: Tuscany, Lombardy, Veneto, Emilia-Romagna)]Marco Mojoli, Giuseppe Musumeci, Giuseppe Tarantini, et al.
American Heart Journal|December 15, 2012
A prospective, randomized trial of intravascular-ultrasound guided compared to angiography guided stent implantation in complex coronary lesions: the AVIO trialAlaide Chieffo, Azeem Latib, Christophe Caussin, et al.
The American Journal of Cardiology|January 30, 2017
Incidence and Management of Restenosis After Treatment of Unprotected Left Main Disease With Second-Generation Drug-Eluting Stents (from Failure in Left Main Study With 2nd Generation Stents-Cardiogroup III Study)Fabrizio D'Ascenzo, Alaide Chieffo, Enrico Cerrato, et al.
International Journal of Cardiology|October 11, 2017
Provisional versus elective two-stent strategy for unprotected true left main bifurcation lesions: Insights from a FAILS-2 sub-studyHiroyoshi Kawamoto, Alaide Chieffo, Fabrizio D'Ascenzo, et al.
European Heart Journal. Acute Cardiovascular Care|September 7, 2021
Acute kidney injury in patients with acute coronary syndrome undergoing invasive management treated with bivalirudin vs. unfractionated heparin: insights from the MATRIX trialAntonio Landi, Mattia Branca, Giuseppe Andò, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 16, 2017
One-year clinical results of the Italian diffuse/multivessel disease ABSORB prospective registry (IT-DISAPPEARS)Luca Testa, Marco De Carlo, Alessandro Petrolini, et al.
International Journal of Cardiology|April 25, 2018
Corrigendum to "Provisional versus elective two-stent strategy for unprotected true left main bifurcation lesions: Insights from a FAILS-2 sub-study" [Int. J. Cardiol. 250 (2018) 80-85]Hiroyoshi Kawamoto, Alaide Chieffo, Fabrizio D'Ascenzo, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|December 25, 2016
Comparison of paclitaxel drug-eluting balloon and paclitaxel-eluting stent in small coronary vessels in diabetic and nondiabetic patients - results from the BELLO (balloon elution and late loss optimization) trialFrancesco Giannini, Azeem Latib, Richard J Jabbour, et al.
The American Journal of Cardiology|January 2, 2021
Incidence, Management, Immediate and Long-Term Outcome of Guidewire and Device Related Grade III Coronary Perforations (from G3CAP - Cardiogroup VI Registry)Enrico Cerrato, Marco Pavani, Umberto Barbero, et al.
Pageof 23